The HEPAMAP is an advocacy tool:
(1) for European hepatologists to highlight the further research needed with a view to influencing the EU research agenda and also;
(2) to raise awareness more generally of liver disease and its links with lifestyle factors such as obesity and alcohol, as well as with metabolic and cardiovascular disease and cancer.
You are invited to join EASL on December 10, 2014 at the European Parliament, Brussels, Belgium, for the launch of the research roadmap for liver disease.
Click here for more HEPAMAP information.
New study evaluates efficacy of PET imaging to manage chronic liver diseases
EASL governing board announces new Vice-Secretary
A web-based program is as effective as group counseling for patients with non-alcoholic fatty liver disease